N. ALAN SELÇUK Et Al. , "Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary," MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2, pp.139-141, 2022
ALAN SELÇUK, N. Et Al. 2022. Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2 , 139-141.
ALAN SELÇUK, N., Demirci, E., Ocak, M., Toklu, T., Ergen, S., & KABASAKAL, L., (2022). Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary. MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2, 139-141.
ALAN SELÇUK, NALAN Et Al. "Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary," MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2, 139-141, 2022
ALAN SELÇUK, NALAN A. Et Al. "Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2, pp.139-141, 2022
ALAN SELÇUK, N. Et Al. (2022) . "Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary." MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , vol.31, no.2, pp.139-141.
@article{article, author={NALAN ALAN SELÇUK Et Al. }, title={Almost Complete Response with a Single Administration Ac-225-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary}, journal={MOLECULAR IMAGING AND RADIONUCLIDE THERAPY}, year=2022, pages={139-141} }